ArticleMedicina (Kaunas, Lithuania)2025

Prognostic Impact of Concomitant Beta-Blocker Use on Survival in EGFR-Mutant Metastatic Non-Small Cell Lung Cancer Patients Treated with Erlotinib.

Oğuzhan Yıldız et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.